CCL5 is secreted by T cells, Platelets, Macrophages, Endothelial cells, and Fibroblasts and stimulates the migration of T cells and monocytes to drive apoptosis of tumor-infiltrating T cells; therefore, it was found that reducing the expression of CCL5 may have a beneficial effect on various tumors (Bai et al., 2020; Korbecki et al., 2020; Nakamura et al., 2021). Here, CCL5 is linked to neoplasm.